Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Welprid 1 (Glimepiride Tablets 1 mg)
Welprid 1 is an oral hypoglycemic agent containing Glimepiride 1 mg, specifically formulated for individuals with type 2 diabetes mellitus. It works by enhancing insulin secretion and improving insulin sensitivity, thereby aiding in better glycemic control. As a second-generation sulfonylurea, it offers a more potent effect with a lower risk of adverse events compared to first-generation agents.
Uses of Welprid 1
Helps regulate blood glucose levels in type 2 diabetes mellitus
Used as monotherapy or in combination with metformin, insulin, or other antidiabetic agents
Supports long-term diabetes management and prevents complications
Benefits of Welprid 1
Effective Glycemic Control – Stimulates insulin release for better blood sugar regulation
Once-Daily Dosing – Ensures convenience and compliance
Proven Safety Profile – Reduced risk of hypoglycemia compared to older sulfonylureas
Supports Beta Cell Function – Helps maintain pancreatic insulin secretion over time
Mechanism of Action of Welprid 1
Glimepiride works by binding to sulfonylurea receptors on pancreatic beta cells, leading to calcium channel activation and insulin release. Additionally, it enhances peripheral glucose uptake, improving overall insulin sensitivity.